Preliminary safety and efficacy of emavusertib (CA-4948) in combination with ibrutinib in relapsed/refractory primary central nervous system lymphoma patients with prior exposure to BTK inhibitor Meeting Abstract
| Authors: | Nowakowski, G. S.; Dabrowska-Iwanicka, A. P.; Grommes, C.; Tun, H. W.; D'Angelo, C.; Burguera, A. D.; Levi, E.; Ramchandren, R.; Ferreri, A. J. M.; Choudhary, G. S.; Zhao, W.; Ferrari, D.; Fowle, M.; Lane, M.; Wang, Ctre; Taszner, M. |
| Abstract Title: | Preliminary safety and efficacy of emavusertib (CA-4948) in combination with ibrutinib in relapsed/refractory primary central nervous system lymphoma patients with prior exposure to BTK inhibitor |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 6020 |
| End Page: | 6021 |
| Language: | English |
| ACCESSION: | WOS:001412527900014 |
| DOI: | 10.1182/blood-2024-208359 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
